Zhongran Chemical plant photo

Strong Custom Synthesis Demand Opens New Export Opportunities in Pharma & Agrochemical Intermediate CDMO

Industry Insights · 2026-10-09

Home › News › Industry Insights
Industry Insights2026-10-09 Source: Taixing Zhongran Chemical Co., Ltd.

Accelerating global drug and crop-protection pipelines are driving continued growth in overseas custom intermediate synthesis outsourcing, opening new growth space for fine chemical OEM/ODM services.

Multinational pharmaceutical and agrochemical companies increasingly prefer Chinese synthesis partners with compliant park-based production and reliable scale-up capability, rather than building capital-intensive plants themselves. Custom intermediate projects typically run in small batches with diverse specifications and strict purity requirements, demanding strong R&D, analytical and flexible production management from suppliers. The ability to rapidly develop routes, study impurities and optimize processes has become the core differentiator.

With 25 years of experience in pharmaceutical, agrochemical and dye intermediates, Taixing Zhongran Chemical Co., Ltd. runs multi-reactor production lines across four bases, supporting frequent product changeovers with a monthly output of 200 tons of fine chemicals. Its own R&D laboratory and full QC equipment form a complete workflow from sample preparation through piloting to commercial scale-up, matching the custom requirements of global buyers.

Market research shows rising procurement demand for specialty agrochemical intermediates and high-grade pharmaceutical intermediates in Europe, Southeast Asia and South America. Overseas customers audit site compliance, wastewater treatment and batch traceability ever more strictly, putting manufacturers located in national-level chemical parks in a stronger position to pass audits and win export orders.